The FEI has announced an adverse analytical finding involving a prohibited substance.
The new case involves the use of O-Desmethyl Venlafaxine, which is a *Banned Substance under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).
Horse: FYF Dutch (FEI ID 103CM43/USA)
Person Responsible Nicki Meuten (FEI ID 10030582/USA)
Event: CEI3* 160 - Coates Creek (CAN) 02.07.2017
Prohibited Substance: O-Desmethyl Venlafaxine
The athlete has been provisionally suspended from the date of notification (16 October 2017) until the FEI Tribunal renders a decision. The horse has been provisionally suspended for two months.
*Notes to Editors:
The FEI’s Prohibited Substances List is divided into two sections - Controlled Medication and *Banned Substances. Controlled Medication substances are those that are regularly used to treat horses, but which must have been cleared from the horse’s system by the time of competition. Banned (doping) substances should never be found in the body of the horse.
In the case of an adverse analytical finding for a Banned Substance, the Person Responsible (PR) is automatically provisionally suspended from the date of notification. The horse is suspended for two months. In the case of a positive for a specified substance, provisional suspension is not automatic.
The FEI has also introduced the concept of Specified Substances. Specified Substances should not in any way be considered less important or less dangerous than other Prohibited Substances. Rather, they are simply substances which are more likely to have been ingested by horses for a purpose other than the enhancement of sport performance, for example, through a contaminated food substance.